Vir Biotechnology, Inc.
NASDAQ:VIRBiotechnology
Healthcare
$9.15 -2.63%
-$0.25 today
- Market cap
- $1.57B
- Beta
- 1.64
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$3.00
52W Low $4.16High $11.66
Volume 2.15M
Average 1.76M
Price history
Vir Biotechnology, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+68.20%
Period high
$13.65
Period low
$5.44
Latest
$9.15
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 424B5 | Nov 12, 2026 | Nov 12, 2026 | |
| S-3ASR | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| SC 13D/A | Nov 6, 2026 | Nov 6, 2026 | |
| 8-K | Nov 4, 2026 | Nov 4, 2026 | |
| 10-Q | Nov 4, 2026 | Nov 4, 2026 | |
| 4 | Nov 4, 2026 | Nov 4, 2026 | |
| 4 | Oct 28, 2026 | Oct 28, 2026 | |
| 8-K | Oct 28, 2026 | Oct 28, 2026 | |
| 3 | Oct 28, 2026 | Oct 28, 2026 | |
| SC 13G/A | Oct 27, 2026 | Oct 27, 2026 | |
| 8-K | Oct 14, 2026 | Oct 14, 2026 | |
| 8-K | Oct 8, 2026 | Oct 8, 2026 | |
| 3 | Oct 6, 2026 | Oct 6, 2026 |
Competitors
Who does Vir Biotechnology, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about VIR's filings, answered from its disclosures.
What is the latest VIR filing?
The latest filing shown is 424B5 dated Nov 12, 2026.
How many recent filings does VIR have?
Intrinsic Alpha currently shows 20 recent filings for VIR.
Continue the stock analysis
Jump to another research area for this company.